Login / Signup

MOV10 sequesters the RNP of influenza A virus in the cytoplasm and is antagonized by viral NS1 protein.

Jian LiSiqi HuFengwen XuShan MeiXiaoman LiuLijuan YinFei ZhaoXiaoxiao ZhaoHong SunZichen XiongDi ZhangShan CenJianwei WangChen LiangFei Guo
Published in: The Biochemical journal (2019)
MOV10 has emerged as an important host antiviral factor. MOV10 not only inhibits various viruses, including human immunodeficiency virus type 1, hepatitis C virus and vesicular stomatitis virus, but also restricts the activity of retroelements long interspersed nucleotide element-1, Alu, SVA and intracisternal A particles. Here, we report that MOV10 suppresses influenza A virus infection through interacting with viral nucleoprotein (NP), sequestering viral RNP in the cytoplasm and causing the degradation of viral vRNA. The antiviral activity of MOV10 depends on the integrity of P-bodies. We also found that the antiviral activity of MOV10 is partially countered by viral NS1 protein that interferes with the interaction of MOV10 with viral NP and causes MOV10 degradation through the lysosomal pathway. Moreover, NS1-defective influenza A virus is more susceptible to MOV10 restriction. Our data not only expand the antiviral spectrum of MOV10 but also reveal the NS1 protein as the first viral antagonist of MOV10.
Keyphrases
  • sars cov
  • human immunodeficiency virus
  • hepatitis c virus
  • dengue virus
  • protein protein
  • antiretroviral therapy
  • amino acid
  • machine learning
  • binding protein
  • big data